Haemonetics Corporation operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haemonetics with three other
companies in this sector in the United States:
Abiomed, Inc.
(2019
sales of $769.43 million
of which 96%
was Impella product revenue),
Angiodynamics, Inc.
($270.63 million
of which 44%
was Vascular Interventions & Therapies), and
Accuray Inc
($418.79 million
of which 53%
was Service).
Sales Analysis.
Haemonetics reported sales of $967.58 million
for the
fiscal
year ending
March of 2019.
This
represents
an
increase of 7.0%
versus 2018, when the company's sales were $903.92 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Haemonetics had sales
of $938.51 million.
Sales of North America Plasma saw an increase
that was more than double the company's growth rate: sales were up
18.6% in 2019, from
$333.83 million to $395.92 million.
Not all segments of Haemonetics experienced an increase in sales in 2019:
sales of Europe,middle East and Africa fell 7.3% to $169.86 million.